Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Annals of the New York Academy of Sciences 667 (1992), S. 0 
    ISSN: 1749-6632
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Natural Sciences in General
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Annals of oncology 9 (1998), S. 589-600 
    ISSN: 1569-8041
    Keywords: brain neoplasms ; chemotherapy ; gene therapy ; glioma ; immunotherapy ; review literature
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Despite more than two decades of clinical research with chemotherapy, theoutcome of malignant gliomas remains poor. Recent years have seen majoradvances in elucidation of the biology of these tumors, which in turn haveled to the current development of innovative therapeutic strategies. Thequestion confronting us at the end of the 1990s is whether we shouldcontinue to use and investigate chemotherapy or whether the time has comefor experimental treatments. As a contribution to this debate, we reviewed the abundant literature onchemotherapy of malignant glioma, paying special attention to methodologicalfeatures. The new treatment approaches based on current knowledge aboutglioma biology are then briefly summarized. Assessment of more than 20 years of chemotherapy trials is discouragingdespite a few areas of modest success. Only patients with specific histology(oligodendroglioma, anaplastic astrocytoma) and good prognostic factors (youngage, good performance status) may benefit from chemotherapy, with a possiblereversal of neurological dysfunction. However, the real impact on survival issmall (anaplastic astrocytoma) or undefined (oligodendroglioma). Furthermore,it is unfortunately obvious that the outcome of glioblastoma patients is notsignificantly modified by chemotherapy. We believe the time has come toexplore the potential of novel biological therapies in glioblastoma patients.This could also be proposed for anaplastic astrocytoma and oligodendrogliomapatients after failure of chemotherapy.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Cancer chemotherapy and pharmacology 6 (1981), S. 195-196 
    ISSN: 1432-0843
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Thirteen patients with small cell carcinoma of the bronchus that had become resistant to conventional chemotherapy were given 4′-(9-acridinylamino) methanesulphon-m-anisidide (mAMSA) at a dose of 90 or 120 mg/m2 at 3-week intervals. Twenty percent of the courses at 90 mg/m2 produced marked myelosuppression. No responses were observed. Median survival from the start of treatment with mAMSA was 5 weeks.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Virchows Archiv 415 (1989), S. 551-557 
    ISSN: 1432-2307
    Keywords: Actin isoforms ; Myofibroblasts ; Desmoplasia ; Gut development ; Carcinoma of the colon
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Experimental evidence has shown that fetal gut mesenchymal cells can modulate epithelial cell differentiation. It is postulated that reciprocal stromal-epithelial interactions in the digestive tract are maintained beyond embryonic life. The mature colonic mucosa contains pericryptal fibroblasts (PCF), a stromal cell type exhibiting smooth muscle morphological features, which are thought to regulate the growth and differentiation of adjacent epithelial cells. Using an antibody directed at α-smooth muscle actin, which is constantly expressed in smooth muscle cells, we performed an immunohistochemical study on human embryonic tissues to assess PCF differentiation during development. PCF expressing ct-smooth muscle actin were first detected around the 21st week of gestation, at the bases of the crypts; the number of differentiated PCF increased then progressively, in synchrony with epithelial proliferation, to achieve at birth the characteristic distribution found in adults. We analyzed a series of non-malignant and malignant epithelial proliferative lesions of the adult colon by the same technique. Only sparse immunoreactive PCF were observed in 10/10 pure tubular adenomas, whereas in 11/11 villous adenomas immunoreactive PCF were consistently found bordering proliferative epithelia. Interestingly, 3/5 papillary adenomas, associated with areas of moderate to marked dysplasia, demonstrated foci of multi-layered immunoreactive PCF. In 14/14 carcinomas examined, PCF were no longer recognizable; stromal cells expressing variable amounts of β-smooth muscle actin, constituting the desmoplastic reaction, were constantly present. These observations establish immunohistochemically a smooth muscle phenotypic feature of PCF, which is acquired at mid-gestation, and the ability of PCF to proliferate in conjunction with some epithelial neoplasias. These findings might help to clarify the histogenesis of PCF and to improve our understanding of the mesenchymal-epithelial interactions suspected to operate during organogenesis as well as benign and malignant neoplastic conditions.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1569-8041
    Keywords: breast cancer ; carboplatinum ; chemotherapy ; continuous 5-fluorouracil
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract We performed a trial using the combination of epirubicin 50mg/m2/day 1, carboplatinum AUC 5/day 1 and continuous5-fluorouracil (5-FU) 200 mg/m2/day (every 4 weeks for6 months) to confirm the efficacy and low toxicity profile of thisregimen in breast cancer. In 51 patients with metastatic(n = 33) or locally advanced (n = 18)breast cancer the overall response rate was 86% (95% confidenceinterval (95% CI): 73%–94%): 94% in locallyadvanced and 81% metastatic disease. Grade 3–4 toxicity was low:4% of patients presented with febrile neutropenia, 16% withsevere palmar-plantar syndrome, 10% with Port-a-cath thrombosis. This study confirms the high efficacy of infusional 5-FU-based regimens andjustifies further research into novel promising oral 5-FU derivatives.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    Annals of oncology 11 (2000), S. 1131-1135 
    ISSN: 1569-8041
    Keywords: attitudes ; breast neoplasms ; genetic predisposition testing ; genetic screening ; knowledge ; ovarian neoplasms ; physician's role ; practice
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background:Primary health care providers are expected to bedirectly involved in the genetic testing for cancer susceptibility. This studyassessed physicians' knowledge, attitude and perception of their role towardstesting for hereditary breast–ovarian cancer. Design:A mail-in survey was sent to all general practitioners,internists, obstetrician-gynecologists and oncologists in private practice inGeneva county, Switzerland. Questions included socio-demographic variables,knowledge about hereditary breast–ovarian cancer, attitude towardstesting and assessment of their role in the pre- and post-test procedure. Results:Two hundred fifty-nine (65%) of four hundredquestionnaires were returned of which two hundred forty-three (61%)were analysed. Response rates were similar between specialties; women answeredmore frequently. The majority of the respondents (87%) approved ofgenetic susceptibility testing. The most common objection to testing was theabsence of approved strategies for the prevention and detection of earlybreast cancer. Most physicians felt they had an active part to play in thepre-test procedure, the disclosure of results, and especially the consultants'long-term care and support (99%). Physicians correctly answered a third(32%) of the knowledge questions. The abstention rate for individualitems ranged from 13% to 60%. Scores varied by specialty.Oncologists were more knowledgeable than gynecologists, internists and generalpractitioners. Conclusions:The majority of the primary care physicians in thisstudy have a favourable attitude and are ready to play a prominent role ingenetic counseling and testing for breast–ovarian cancer predisposition.Defective knowledge scores, however, underline the need for targetededucational programs.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    New York, NY [u.a.] : Wiley-Blackwell
    Journal of Cellular Physiology 153 (1992), S. 129-139 
    ISSN: 0021-9541
    Keywords: Life and Medical Sciences ; Cell & Developmental Biology
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Biology , Medicine
    Notes: It has been proposed that a finely tuned protease-anti-protease equilibrium must be mainted during process of cell migration in order to limit extracellular proteolysis to the close proxmity of the cell surface, and therby to prevent excessive extracellular matrix degradation. We have previously shown that urokinase-type plasminogen activator (u-PA) activity is induced in microvascular endothelial cells migrating from the edges of a wounded monolayer in vitro (Pepper et al., J. Cell Biol., 105:2535-2541, 1987). By Northern analysis, we now demonstrate that plasminogen activator inhibitor 1 (Pal-1) mRNA is increased in multiple-wounded monolayers of bovine microvascular (BME) or aortic (BAE) endothelial cells, with a maximal 7- and 9-fold increase 4 h after wounding, respectively. By in situ hybridization, we demonstrate that the increase in PAI-1 mRNA in localized to cells at the edge of a wounded BME or BAE cell monolayer. The increase in PAI-1 mRNA observe in BME cells is independent of cell division and is inhibited by antibodies to basic fibroblast growth factor (bFGF), suggesting that PAI-1 induction in migrating cells is mediated by the autocrine activity of bFGF. Taken together with our previous observations on the induction of u-PA, these results support the hypothesis that the proteolytic balance in the pericellular environment of migrating cells is regulated through the concomitant production of proteases and protease inhibitors. © 1992 Wiley-Liss, Inc.
    Additional Material: 7 Ill.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...